Telix Pharmaceuticals Ltd
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies.
The business
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
Small Caps Research
No research on Telix Pharmaceuticals Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise TLX based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Weekly wrap: Aussie shares sink 0.6% as US Bonds defy Bessent intervention
ASX slips 0.6% for the week as US yields rise despite Bessent's bid to push rates lower; property and tech slide, Zip plunges 15% amid inflation jitters.
ASX Weekly Wrap: Narrow Leadership, Sticky Core Inflation & Weak Aussie
ASX 200 near 8,764 as Judo Capital dives 39% on funding-cost fears; week capped by hawkish Fed, sticky core inflation and volatile leadership.
Five New Stocks For The Healthcare Sector Rotation: PME, TLX, TNE, 360, and SDR
ASX healthcare rotation heats up as PME, TLX, TNE, 360, SDR emerge—five stocks positioned to ride the sector shift amid oil, inflation and volatility.
SmallCaps Weekly Wrap & New Fundie Picks
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.